USPTO serial 78235115
P.O.W.E.R. PATIENT OUTCOME WITH BEXTRA REGIMEN
Reviewed by CopyMark Law Group
Reg. 2895348Status 711
- Filing date
- Status date
- Registration date
- Oct 19, 2004
- Examiner
- COGGINS, ROBERT H
- Law office
- TMO LAW OFFICE 115
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with P.O.W.E.R. PATIENT OUTCOME WITH BEXTRA REGIMEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PHARMACIA & UPJOHN COMPANY, INC.
NEW YORK, NY
Peapack, NJ
Peapack, NJ
Peapack, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANE UNGARO
JANE UNGARO Pfizer Inc.150 East 42nd StreetTrademark Department -2nd FloorNEW YORK, NY 10017Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals in the nature of anti-inflammatory analgesics | SECTION 7(e) - CANCELLED | Feb 11, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARMACIA & UPJOHN COMPANY, INC.
- Other trademarks owned by Pharmacia & Upjohn Company
- Other trademarks owned by Pharmacia & Upjohn Company
- Other trademarks owned by Pharmacia & Upjohn Company
- Other trademarks in Class 005
- Similar marks named P.O.W.E.R. PATIENT OUTCOME WITH BEXTRA REGIMEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 29, 2011 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Nov 5, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 1, 2010 | C7RF | REQUEST FOR SECT 7 TOTAL SURRENDER FILED | — |
| Nov 1, 2010 | ES7S | TEAS SECTION 7 SURRENDER RECEIVED | — |
| Aug 5, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 19, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 27, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 4, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 25, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 5, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 22, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 22, 2004 | IUAA | USE AMENDMENT ACCEPTED | — |
| Feb 27, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2004 | PAPER RECEIVED | — | |
| Aug 27, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2003 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Jun 23, 2003 | CFIT | CASE FILE IN TICRS | — |
| Apr 18, 2003 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Apr 18, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2003 | IUAF | USE AMENDMENT FILED | — |
| Apr 18, 2003 | PAPER RECEIVED | — |